Atlas Trials

The BARCODE 2 Study - The Use of Genetic Profiling to Guide Prostate Cancer Treatment

Clinical trial NCT02955082 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02955082
Sponsor
Institute of Cancer Research, United Kingdom
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Hormone Refractory Prostate Cancer
Start date
2017-05-25
Primary completion
2026-12-31
Enrollment
305

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.